• 1
    Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med 2003: 349: 776788.
  • 2
    Auchus RJ, Miller WL. Congenital adrenal hyperplasia – more dogma bites the dust. J Clin Endocrinol Metab 2012: 97: 772775.
  • 3
    Bachega TA, Billerbeck AE, Madureira G et al. Molecular genotyping in Brazilian patients with the classical and nonclassical forms of 21-hydroxylase deficiency. J Clin Endocrinol Metab 1998: 83: 44164419.
  • 4
    Wilson RC, Nimkarn S, Dumic M et al. Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Mol Genet Metab 2007: 90: 414421.
  • 5
    Finkielstain GP, Chen W, Mehta SP et al. Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2011: 96: E161E172.
  • 6
    Giwercman YL, Nordenskjöld A, Ritzén EM et al. An androgen receptor gene mutation (E653K) in a family with congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency as well as in partial androgen insensitivity. J Clin Endocrinol Metab 2002: 87: 26232628.
  • 7
    Bachega TA, Billerbeck AE, Parente EB et al. Multicentric study of Brazilian patients with 21-hydroxylase deficiency: a genotype-phenotype correlation. Arq Bras Endocrinol Metabol 2004: 48: 697704.
  • 8
    Sugiyama Y, Mizuno H, Hayashi Y et al. Severity of virilization of external genitalia in Japanese patients with salt-wasting 21-hydroxylase deficiency. Tohoku J Exp Med 2008: 215: 341348.
  • 9
    Goossens K, Juniarto AZ, Timmerman MA et al. Lack of correlation between phenotype and genotype in untreated 21-hydroxylase-deficient Indonesian patients. Clin Endocrinol (Oxf) 2009: 71: 628635.
  • 10
    Yang HY, Lee QP, Rettie AE, Juchau MR. Functional cytochrome P4503A isoforms in human embryonic tissues: expression during organogenesis. Mol Pharmacol 1994: 46: 922928.
  • 11
    Stevens JC, Hines RN, Gu C et al. Developmental expression of the major human hepatic CYP3A enzymes. J Pharmacol Exp Ther 2003: 307: 573582.
  • 12
    Rodriguez-Antona C, Jande M, Rane A, Ingelman-Sundberg M. Identification and phenotype characterization of two CYP3A haplotypes causing different enzymatic capacity in fetal livers. Clin Pharmacol Ther 2005: 77: 259270.
  • 13
    Rodriguez-Antona C, Axelson M, Otter C, Rane A, Ingelman-Sundberg M. A novel polymorphic cytochrome P450 formed by splicing of CYP3A7 and the pseudogene CYP3AP1. J Biol Chem 2005: 280: 2832428331.
  • 14
    Smit P, van Schaik RH, van der Werf M et al. A common polymorphism in the CYP3A7 gene is associated with a nearly 50% reduction in serum dehydroepiandrosterone sulfate levels. J Clin Endocrinol Metab 2005: 90: 53135316.
  • 15
    Goodarzi MO, Xu N, Azziz R. Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2008: 93: 29092912.
  • 16
    Vyhlidal CA, Gaedigk R, Leeder JS. Nuclear receptor expression in fetal and pediatric liver: correlation with CYP3A expression. Drug Metab Dispos 2006: 34: 131137.
  • 17
    Hustert E, Zibat A, Presecan-Siedel E et al. Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4. Drug Metab Dispos 2001: 29: 14541459.
  • 18
    Ikeda S, Kurose K, Jinno H et al. Functional analysis of four naturally occurring variants of human constitutive androstane receptor. Mol Genet Metab 2005: 86: 314319.
  • 19
    Wang XD, Li JL, Su QB et al. Impact of the haplotypes of the human pregnane X receptor gene on the basal and St John's wort-induced activity of cytochrome P450 3A4 enzyme. Br J Clin Pharmacol 2009: 67: 255261.
  • 20
    Prader A. Genital findings in the female pseudo-hermaphroditism of the congenital adrenogenital syndrome; morphology, frequency, development and heredity of the different genital forms. Helv Paediatr Acta 1954: 9: 231248.
  • 21
    Bachega TA, Billerbeck AE, Madureira G et al. Low frequency of CYP2B deletions in Brazilian patients with congenital adrenal hyperplasia due to 21-hydroxylas deficiency. Hum Hered 1999: 49: 914.
  • 22
    Paulino LC, Araujo M, Guerra G Jr, Marini SH, De Mello MP. Mutation distribution and CYP21/C4 locus variability in Brazilian families with the classical form of the 21-hydroxylase deficiency. Acta Paediatr 1999: 88: 275283.
  • 23
    Costa-Barbosa FA, Tonetto-Fernandes VF, Carvalho VM et al. Superior discriminating value of ACTH-stimulated serum 21-deoxycortisol in identifying heterozygote carriers for 21-hydroxylase deficiency. Clin Endocrinol (Oxf) 2010: 73: 700706.
  • 24
    Speiser PW, Dupont J, Zhu D et al. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 1992: 90: 584595.
  • 25
    Welzel M, Schwarz HP, Hedderich J et al. No correlation between androgen receptor CAG and GGN repeat length and the degree of genital virilization in females with 21-hydroxylase deficiency. J Clin Endocrinol Metab 2010: 95: 24432450.
  • 26
    Burk O, Tegude H, Koch I et al. Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine. J Biol Chem 2002: 277: 2428024288.
  • 27
    Du J, Shi Y, Zhang A et al. Screening for SNPs and haplotypes in the CYP3A7 gene in Chinese populations. Pharmacogenomics 2007: 8: 559566.
  • 28
    Billerbeck AE, Bachega TA, Frazatto ET et al. A novel missense mutation, GLY424SER, in Brazilian patients with 21-hydroxylase deficiency. J Clin Endocrinol Metab 1999: 84: 28702872.
  • 29
    Billerbeck AE, Mendonca BB, Pinto EM, Madureira G, Arnhold IJ, Bachega TA. Three novel mutations in CYP21 gene in Brazilian patients with the classical form of 21-hydroxylase deficiency due to a founder effect. J Clin Endocrinol Metab 2002: 87: 43144317.
  • 30
    Lau IF, Soardi FC, Lemos-Marini SH, Guerra G Jr, Jr BMT, De Mello MP. H28 + C insertion in the CYP21 gene: a novel frameshift mutation in a Brazilian patient with the classical form of 21-hydroxylase deficiency. J Clin Endocrinol Metab 2001: 86: 58775880.
  • 31
    Coeli FB, Soardi FC, Bernardi RD et al. Novel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiency. BMC Med Genet 2010: 11: 104.
  • 32
    Stikkelbroeck NM, Hoefsloot LH, de Wijs IJ, Otten BJ, Hermus AR, Sistermans EA. CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations. J Clin Endocrinol Metab 2003: 88: 38523859.
  • 33
    Rocha RO, Billerbeck AE, Pinto EM et al. The degree of external genitalia virilization in girls with 21-hydroxylase deficiency appears to be influenced by the CAG repeats in the androgen receptor gene. Clin Endocrinol (Oxf) 2008: 68: 226232.
  • 34
    Kamrath C, Hochberg Z, Hartmann MF, Remer T, Wudy SA. Increased activation of the alternative “backdoor” pathway in patients with 21-hydroxylase deficiency: evidence from urinary steroid hormone analysis. J Clin Endocrinol Metab 2012: 97: 367375.
  • 35
    Zhang B, Xie W, Krasowski MD. PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics. Pharmacogenomics 2008: 9: 16951709(Review).
  • 36
    Goode DL, Cooper GM, Schmutz J et al. Evolutionary constraint facilitates interpretation of genetic variation in resequenced human genomes. Genome Res 2010: 20: 301310.
  • 37
    Wyen C, Hendra H, Siccardi M et al. German Competence Network for HIV/AIDS Coordinators. Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens. J Antimicrob Chemother 2011: 66: 20922098.